{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"20"},{"groupId":"OG004","value":"17"},{"groupId":"OG005","value":"14"},{"groupId":"OG006","value":"23"},{"groupId":"OG007","value":"10"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"20"},{"groupId":"OG004","value":"17"},{"groupId":"OG005","value":"14"},{"groupId":"OG006","value":"23"},{"groupId":"OG007","value":"10"}],"units":"Participants"}],"title":"Day 29"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"16"},{"groupId":"OG004","value":"13"},{"groupId":"OG005","value":"12"},{"groupId":"OG006","value":"21"},{"groupId":"OG007","value":"10"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"13"},{"groupId":"OG005","value":"13"},{"groupId":"OG006","value":"22"},{"groupId":"OG007","value":"10"}],"units":"Participants"}],"title":"Day 60"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"9"},{"groupId":"OG005","value":"13"},{"groupId":"OG006","value":"18"},{"groupId":"OG007","value":"7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"19"},{"groupId":"OG004","value":"11"},{"groupId":"OG005","value":"14"},{"groupId":"OG006","value":"21"},{"groupId":"OG007","value":"8"}],"units":"Participants"}],"title":"Day 90"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"8"},{"groupId":"OG005","value":"9"},{"groupId":"OG006","value":"13"},{"groupId":"OG007","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"16"},{"groupId":"OG004","value":"13"},{"groupId":"OG005","value":"10"},{"groupId":"OG006","value":"18"},{"groupId":"OG007","value":"7"}],"units":"Participants"}],"title":"Day 180"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"9"},{"groupId":"OG005","value":"7"},{"groupId":"OG006","value":"8"},{"groupId":"OG007","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"11"},{"groupId":"OG005","value":"10"},{"groupId":"OG006","value":"14"},{"groupId":"OG007","value":"5"}],"units":"Participants"}],"title":"Day 270"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"4"},{"groupId":"OG006","value":"8"},{"groupId":"OG007","value":"3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"12"},{"groupId":"OG005","value":"8"},{"groupId":"OG006","value":"14"},{"groupId":"OG007","value":"5"}],"units":"Participants"}],"title":"Day 365"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"3"},{"groupId":"OG007","value":"2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"8"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"11"},{"groupId":"OG007","value":"3"}],"units":"Participants"}],"title":"Day 545"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"1"},{"groupId":"OG007","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"5"},{"groupId":"OG007","value":"1"}],"units":"Participants"}],"title":"Day 730"}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"20"},{"groupId":"OG004","value":"17"},{"groupId":"OG005","value":"14"},{"groupId":"OG006","value":"23"},{"groupId":"OG007","value":"10"}],"units":"Participants"}],"description":"Pharmacokinetics persistence of JCARH125 CAR T cells in the blood as determined by quantitative polymerase chain reaction (qPCR) over time to detect the JCARH125 transgene. Persistence is defined as a transgene count greater than or equal to the lower limit of detection (LLOD).","groups":[{"description":"JCARH125 IV at dose level 50 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG000","title":"Phase 1 50 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 150 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG001","title":"Phase 1 150 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 300 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG002","title":"Phase 1 300 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 450 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG003","title":"Phase 1 450 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 600 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG004","title":"Phase 1 600 x 10^6 Cells"},{"description":"2 doses of 100 mg anakinra administered subcutaneously (SC) for 5 consecutive days + JCARH125 IV at dose level 600 x 10\\^6 consisting of CD3+CAR+T cells","id":"OG005","title":"Phase 1 Anakinra 600 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 600 x 10\\^6 consisting of CD3+CAR+T cells expansion","id":"OG006","title":"Phase 2 600 x 10^6 Cells"},{"description":"JCARH125 IV at dose level 600 x 10\\^6 consisting of CD3+CAR+T cells in participants previously treated with BCMA-directed anti-myeloma therapy","id":"OG007","title":"Phase 2a 600 x 10^6 Cells Anti-BCMA"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All participants who have the necessary PK measurements to provide interpretable results for the specific parameters of interest","reportingStatus":"POSTED","timeFrame":"Day 29, 60, 90, 180, 270, 365, 545, 730","title":"Number of Participants With Pharmacokinetics Persistence","type":"SECONDARY","unitOfMeasure":"Participants"}